Hillrom (Chicago, IL) announced the launch of two new respiratory therapy devices: the Volara System, which provides hospital-grade oscillation and lung expansion (OLE) therapy, and the Synclara Cough System. The Volara System delivers OLE therapy, combining Continuous Positive Expiratory Pressure (CPEP), Continuous High-Frequency Oscillation (CHFO) and a nebulizer in one portable, lightweight device.
The Volara System is versatile, enabling patients to continue receiving OLE treatments with the precise settings they used in the hospital, at home, Hillrom says. Volara can be used with a mouthpiece, face mask, tracheostomy or in-line on a ventilator.
The Synclara Cough System is a non-invasive therapy that simulates a cough to remove secretions in patients with compromised peak cough flow. Synclara has been designed with the programmability and sensing technology to deliver a more individualized treatment, the portability and ease-of-use to improve the patient experience, and specialized patient training, therapy optimization and support.
Both the Volara System and Synclara Cough System are available in the U.S.